Tech Company Financing Transactions
ExcepGen Funding Round
RA Capital Management, Apollo Projects and Gravity Fund participated in a $4 million capital raise for ExcepGen. The financing round was announced on 8/24/2023.
Transaction Overview
Company Name
Announced On
8/24/2023
Transaction Type
Venture Equity
Amount
$4,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to accelerate its research and development efforts, as well as advance its collaborations with other companies.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
780 Bryant St.
San Francisco, CA 94107
USA
San Francisco, CA 94107
USA
Phone
Undisclosed
Website
Email Address
Overview
ExcepGen is a venture-backed, early stage biotechnology company located in San Francisco. The company is focused on solving fundamental underlying problems in drug discovery and applying those solutions to create a new generation of therapeutics.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Thomas Folliard
Chief Operating Officer
Katherine Barcay
Chief Scientific Officer
Barbara Mertins
Browse more venture capital transactions:
Prev: 8/24/2023: Neurowyzr venture capital transaction
Next: 8/25/2023: Irys Insurtech venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs